Skip to main content
. 2020 Nov 11;30(6):403–408. doi: 10.4103/ijn.IJN_260_19

Table 2.

Incidence of CIN in different groups according to different definitions of CIN

Groups Total n=434 Group A* n=149 Group B n=145 Group C n=140 P
Cr after 48 h 1.99±0.77 2.05±0.81 1.90±0.63 2.00±0.85 0.27
CIN0.5§ 8.1% (35) 6.8% (10) 6.9% (10) 10.8% (15) 0.38
CIN0.3|| 12.4% (53) 9.7% (14) 13.3% (19) 14.4% (20) 0.44
CIN25%# 8.1% (35) 6.1% (9) 7.6% (11) 10.8% (15) 0.34

*Group A=IV NAC, Group B=Oral NAC, Group C=Placebo group, §CIN0.5=CIN defined by absolute 0.5 mg/dL increase of serum Cr from baseline, ||CIN0.3=CIN defined by absolute 0.3 mg/dL increase of serum Cr from baseline, #CIN25% = CIN defined by relative 25% increase of serum Cr from baseline